Cnam 2027 Report: Deprescription as a Strategic Lever for Healthcare Savings
The French National Health Insurance fund, known as the Caisse nationale de l’Assurance maladie (Cnam), has officially identified “deprescribing” as a central strategy in its 2027 “Charges and Products” report to optimize pharmaceutical expenditure and improve patient safety. This initiative seeks to empower pharmacists to actively participate in the review and potential discontinuation of unnecessary … Read more